Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$50.5M |
| 2 |
Comcast
CMCSA
|
+$31.1M |
| 3 |
Lowe's Companies
LOW
|
+$26.3M |
| 4 |
Occidental Petroleum
OXY
|
+$24.2M |
| 5 |
Ford
F
|
+$24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$44.3M |
| 2 |
Phillips 66
PSX
|
+$34M |
| 3 |
Honeywell
HON
|
+$28.9M |
| 4 |
Intuit
INTU
|
+$28.1M |
| 5 |
RTN
Raytheon Company
RTN
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.74% |
| 2 | Industrials | 16.83% |
| 3 | Healthcare | 15.35% |
| 4 | Consumer Discretionary | 11.7% |
| 5 | Consumer Staples | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Fossil Group
FOSL
$332M
| $4.48M | 0.08% |
358,147
-284,802
| -44% | -$3.22M |
|
302
Omnicell
OMCL
$1.62B
| $4.46M | 0.08% |
61,760
+4,925
| +9% | +$361K |
|
303
Amdocs
DOX
$6.41B
| $4.46M | 0.08% |
67,400
-81,914
| -55% | -$5.26M |
|
304
FedEx
FDX
$76.9B
| $4.42M | 0.08% |
30,358
-93,806
| -76% | -$15.1M |
|
305
Corteva
CTVA
$54.6B
| $4.41M | 0.08% |
157,554
-300,193
| -66% | -$8.68M |
|
306
Bausch Health
BHC
$2.41B
| $4.34M | 0.08% |
198,703
-33,075
| -14% | -$757K |
|
307
Teradyne
TER
$58.7B
| $4.33M | 0.08% |
74,818
-74,641
| -50% | -$3.95M |
|
|
BMCH
308
DELISTED
BMC Stock Holdings, Inc
BMCH
| $4.28M | 0.08% |
163,261
-11,045
| -6% | -$263K |
|
309
Church & Dwight Co
CHD
$23.4B
| $4.26M | 0.08% |
56,628
+24,161
| +74% | +$1.83M |
|
310
Costco
COST
$420B
| $4.24M | 0.07% |
14,705
-1,067
| -7% | -$300K |
|
311
Element Solutions
ESI
$8.6B
| $4.21M | 0.07% |
413,981
+108,330
| +35% | +$1.07M |
|
312
Tetra Tech
TTEK
$9.47B
| $4.21M | 0.07% |
242,830
+5,440
| +2% | +$88.9K |
|
313
Eastman Chemical
EMN
$8.47B
| $4.21M | 0.07% |
56,983
-124,123
| -69% | -$8.91M |
|
314
Timken Company
TKR
$8.67B
| $4.19M | 0.07% |
96,248
-50,663
| -34% | -$2.24M |
|
|
TIF
315
DELISTED
Tiffany & Co.
TIF
| $4.18M | 0.07% |
45,166
-105,348
| -70% | -$9.51M |
|
316
Pilgrim's Pride
PPC
$7.68B
| $4.18M | 0.07% |
130,487
+10,220
| +8% | +$297K |
|
317
TransUnion
TRU
$16.2B
| $4.11M | 0.07% |
+50,647
| New | +$4.07M |
|
318
Laureate Education
LAUR
$5.16B
| $4.09M | 0.07% |
246,509
+130,857
| +113% | +$2.2M |
|
319
Allstate
ALL
$64.2B
| $4.05M | 0.07% |
37,270
-40,830
| -52% | -$4.26M |
|
320
Range Resources
RRC
$9.59B
| $4.05M | 0.07% |
1,060,134
+697,046
| +192% | +$3.35M |
|
|
INFO
321
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $4.01M | 0.07% |
60,018
+39,944
| +199% | +$2.61M |
|
322
Cracker Barrel
CBRL
$1.29B
| $3.97M | 0.07% |
24,393
+10,717
| +78% | +$1.8M |
|
323
Zebra Technologies
ZBRA
$17.4B
| $3.96M | 0.07% |
19,164
+1,575
| +9% | +$318K |
|
|
WW
324
DELISTED
WW International
WW
| $3.91M | 0.07% |
103,398
-103,963
| -50% | -$2.94M |
|
325
Brunswick
BC
$5.24B
| $3.89M | 0.07% |
+74,613
| New | +$3.56M |
|
Similar funds
Joel Greenblatt's Q3 2019 Portfolio in Review
As of Q3 2019, Joel Greenblatt held 1,300 positions worth $5.66B, down 9.7% from $6.27B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $593M in Q3 2019, closing 225 positions and reducing 527 holdings. Its most notable exit was Phillips 66, an estimated $34M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Marathon Petroleum worth $23.5M.
- Joel Greenblatt's largest Q3 2019 buy was Marathon Petroleum: 387,491 shares worth $23.5M.
- Joel Greenblatt added most to Linde in Q3 2019, an estimated $50.5M increase.
- Joel Greenblatt's biggest Q3 2019 reduction was Eli Lilly, cutting an estimated $44.3M.
- Joel Greenblatt fully exited Phillips 66 in Q3 2019, selling an estimated $34M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.66B portfolio in Q3 2019.
- Joel Greenblatt opened 185 new positions and closed 225 in Q3 2019.
- Joel Greenblatt's portfolio value fell 9.7% quarter-over-quarter to $5.66B.
Based on Gotham Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.